Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of Cymbopogon citratus extract in chronic kidney disease stage 3B
TCTR20230720001Phase 2Completed
- Sponsor
- Thai Traditional Medicine Knowledge Fund
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cymbopogon citratus in chronic kidney disease (CKD), sponsored by Thai Traditional Medicine Knowledge Fund. Started Jun 2022; status: completed.
02
Drugs
cymbopogon citratus
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on TCTR20230720001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230720001.